About us

HCD was created out of an alliance with University of Chester, charities and health service sectors in reponse to the ever-growing demand for economic analysis within healthcare and specifically the need for health economics and business intelligence within the public and third sectors.

Through these partnerships, HCD provides a unique insight and perspective, focusing our analyses on what matters to patients as well as decision-makers, all undertaken with academic rigour, independence and credibility.

Continue Reading
Scroll for more

Our Process

We have created core partnerships with University of Chester and leading patient charities that underpin our approach.

Higher education

Academia has a leading role to play in providing an independent, credible evidence-base as well as evaluating current and new ways of delivering healthcare.


Our partnerships with patient charities ensure that any analyses we undertake reflect the day-to-day realities of living with a particular condition.


We apply primary or secondary real world data sources depending on research needs and questions. From ethically reviewed burden of illness studies and bespoke service primary data, to secondary sourced disease registries and episode statistics.

Scroll for more

Latest News

Check out what is happening at HCD Economics

October 2020

George Morgan announces publication in BMJ open

George Morgan (HCD Economics) announces publication in BMJ Open of a study investigating surgical trends, outcomes and disparities in minimal invasive surgery for patients with endometrial cancer. A retrospective cohort study undertaken by HCD Economics, led by Professor Esther Moss of University of Leicester, has recently been published in the September 2020 edition of BMJ Open, (http://dx.doi. org/10.1136/bmjopen-2019- 036222). The study objective was to examine surgical outcomes and trends in the implementation of minimally invasive surgery (MIS) use for endometrial cancer (EC).
Continue Reading
September 2020

The best and most up to date science that the fields of thrombosis and hemostasis have to offer.

Dr Flora Peyvandi, Co-Chair, International Society on Thrombosis and Haemostasis (ISTH 2020) HCD Economics news is reporting our research that was published at ISTH 2020 and our team of health economists also report on ISTH 2020 haemophilia content and latest real world evidence insights from ISTH (for a more comprehensive report, an ‘HCD Economics - RWE perspectives’* dossier is available for all HCD Economics news readers)
Continue Reading
Scroll for more

Get in touch

...and one of our experts will get back to you ASAP.

Please be advised that we will not use your details for marketing purposes
Scroll for more